Related Experiment Video
Updated: Jun 8, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA regulation of growth factor receptor signaling in human cancer cells
Keith M Giles1, Andrew Barker, Priscilla M Zhang
1Laboratory for Cancer Medicine, Centre for Medical Research, Western Australian Institute for Medical Research, University of Western Australia, Perth, WA, Australia.
Abstract:
Aberrant expression of the epidermal growth factor receptor (EGFR) and/or human epidermal growth factor receptor 2 (HER2) is a feature of many human tumors and is associated with disease progression, treatment resistance, and poor prognosis. Protein kinase B/Akt, an important downstream effector of these receptor tyrosine kinases, induces signaling pathways that control cancer cell proliferation, invasion, angiogenesis, and apoptosis resistance. MicroRNAs (miRNAs), small noncoding RNAs that bind to the 3'-untranslated region of target mRNAs, are now recognized to play key roles in the regulation of gene expression, particularly in tumor development and metastasis. We have shown that miRNA-7 (miR-7) and miRNA-331-3p (miR-331-3p) directly regulate expression of EGFR and HER2, respectively, in glioblastoma and prostate cancer cell lines. As a consequence, miR-7 and miR-331-3p reduce Akt activity and thus have the capacity to regulate a signaling pathway critical to the development and progression of glioblastoma and prostate cancer. This chapter provides a detailed approach outlining how to confirm that a putative target of a miRNA is a direct target, and subsequent assessment of downstream signaling mediators.
Insights
MicroRNAs miR-7 and miR-331-3p directly regulate epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) respectively. This regulation impacts the Akt signaling pathway, crucial for glioblastoma and prostate cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Aberrant expression of EGFR and HER2 is common in human tumors, correlating with poor prognosis and treatment resistance.
- The Akt signaling pathway, a downstream effector of EGFR/HER2, is vital for cancer cell proliferation, invasion, angiogenesis, and apoptosis resistance.
- MicroRNAs (miRNAs) are key regulators of gene expression, implicated in tumor development and metastasis.
Purpose of the Study:
- To investigate the role of specific miRNAs in regulating EGFR and HER2 expression in cancer.
- To determine if miR-7 and miR-331-3p directly target EGFR and HER2, respectively.
- To assess the impact of this miRNA-mediated regulation on the Akt signaling pathway in glioblastoma and prostate cancer.
Main Methods:
- Directly validated miRNA targeting of EGFR and HER2 in glioblastoma and prostate cancer cell lines.
- Assessed the downstream effects of miRNA-mediated EGFR/HER2 regulation on Akt signaling.
- Detailed methodology for confirming direct miRNA-target interactions and analyzing downstream signaling.
Main Results:
- Demonstrated that miR-7 directly targets EGFR and miR-331-3p directly targets HER2 in relevant cancer cell lines.
- Showed that this direct regulation leads to reduced Akt activity.
- Established a functional link between these miRNAs, their targets (EGFR/HER2), and the critical Akt pathway.
Conclusions:
- miR-7 and miR-331-3p are direct negative regulators of EGFR and HER2, respectively.
- These miRNAs modulate the Akt signaling pathway, offering potential therapeutic avenues for EGFR/HER2-driven cancers.
- The findings provide a framework for validating miRNA-target interactions and their functional consequences in cancer.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
MicroRNAs
MicroRNAs

